Compare ESTA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | POET |
|---|---|---|
| Founded | 2004 | 1972 |
| Country | United States | Canada |
| Employees | N/A | 80 |
| Industry | Industrial Specialties | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2018 | 2008 |
| Metric | ESTA | POET |
|---|---|---|
| Price | $69.40 | $12.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $86.86 | N/A |
| AVG Volume (30 Days) | 485.3K | ★ 47.9M |
| Earning Date | 05-06-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,208,000.00 | N/A |
| Revenue This Year | $28.05 | $848.96 |
| Revenue Next Year | $26.21 | $700.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $33.35 | $3.87 |
| 52 Week High | $83.31 | $20.65 |
| Indicator | ESTA | POET |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 50.35 |
| Support Level | $68.75 | $11.82 |
| Resistance Level | $74.41 | $15.50 |
| Average True Range (ATR) | 3.76 | 2.06 |
| MACD | -0.02 | -0.37 |
| Stochastic Oscillator | 46.98 | 8.14 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.